Ceramide Containing Multivesicular Emulsion Application . . .
Primary Purpose
Foot Transepidermal Water Loss in Patients in NIDDM, Foot Dryness in Patients With NIDDM
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
CeraVe
Sponsored by

About this trial
This is an interventional treatment trial for Foot Transepidermal Water Loss in Patients in NIDDM
Eligibility Criteria
Inclusion Criteria:
- >18 years of age
- non insulin-dependent diabetes
- moderate to severe xerosis of both feet [a score of at least 4 on a scale of 0 (normal) to 8 (deep fissuring)]
- capable of understanding and signing consent form
Exclusion Criteria:
- history of ichthyosis vulgaris
- known hypersensitivity to the topical product used in the study
- previous use of high potency steroids (class I and II) in past 2 week
- presence of acute skin disease or infection, such as vasculitis or cellulitis
- presence of foot ulcer
- evidence of gangrene
Sites / Locations
Outcomes
Primary Outcome Measures
Decrease transepidermal water loss and foot dryness in study subjects.
Secondary Outcome Measures
Full Information
NCT ID
NCT00947726
First Posted
July 27, 2009
Last Updated
April 18, 2011
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1. Study Identification
Unique Protocol Identification Number
NCT00947726
Brief Title
Ceramide Containing Multivesicular Emulsion Application . . .
Official Title
Ceramide Containing Multivesicular Emulsion Application as a Skin Hydration Treatment for Feet of Subjects With Non-insulin Dependent Diabetes Mellitus.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2011
Overall Recruitment Status
Completed
Study Start Date
July 2009 (undefined)
Primary Completion Date
October 2009 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
We believe that using a ceramide based foot cream two times a day for two weeks will prevent water loss and overall foot dryness in patients with non-insulin dependent diabetes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Foot Transepidermal Water Loss in Patients in NIDDM, Foot Dryness in Patients With NIDDM
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
CeraVe
Other Intervention Name(s)
Ceramide based foot cream
Intervention Description
Using OTC cream on foot twice daily for two weeks.
Primary Outcome Measure Information:
Title
Decrease transepidermal water loss and foot dryness in study subjects.
Time Frame
5 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
>18 years of age
non insulin-dependent diabetes
moderate to severe xerosis of both feet [a score of at least 4 on a scale of 0 (normal) to 8 (deep fissuring)]
capable of understanding and signing consent form
Exclusion Criteria:
history of ichthyosis vulgaris
known hypersensitivity to the topical product used in the study
previous use of high potency steroids (class I and II) in past 2 week
presence of acute skin disease or infection, such as vasculitis or cellulitis
presence of foot ulcer
evidence of gangrene
12. IPD Sharing Statement
Learn more about this trial
Ceramide Containing Multivesicular Emulsion Application . . .
We'll reach out to this number within 24 hrs